India is urged to resist US pressure to rein in its affordable medicines policiesBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4119 (Published 25 July 2016) Cite this as: BMJ 2016;354:i4119
- Sophie Cousins
India must not bow to pressure from the US government and drug companies to curb the development of quality affordable generic medicines, global leaders attending the International Aids Conference in Durban, South Africa, have warned.
India has provided more than 80% of the world’s generic anti-HIV drugs used around the world, but activists, experts, and leaders were concerned that Narendra Modi’s government would bow to outside pressure and change its policies on affordable medicines, with potentially serious consequences for people with HIV.
Leena Menghaney, from the Médecins Sans …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial